Richard G. Bach

Also affiliated with Clinical Research Institute, Duke Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial”.

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01505-4

N/A

3.8DataRank · unranked

134 citations

Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever +40 more

Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Circulation Heart Failure(2024)10.1161/circheartfailure.124.011663

N/A

0.328DataRank · unranked

7 citations

Danielle S. Burstein, Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka +19 more

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010314

N/A

0DataRank · unranked

1 citations

Mitra Mastali, Jennifer E. Van Eyk, E. John Orav, Christoffer Rasmus Vissing, Sharlene M. Day +27 more